Nurse Practitioner, Family · Van Nuys, CA
NPI
1316393820
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13754 Victory Blvd
Van Nuys, CA, 91401
Phone (818) 616-1373
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
599 services
Medicare patients, 2024
276
Average age 73
Drug cost, 2024
$2.6M
14,853 prescriptions
Company payments, 2025
$72.79
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Mezentseva was code 99214 (office e&m - established), 320 times for 196 patients. In total Anna Mezentseva billed 599 services in 19 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 320 | 196 | $89.19 | $29K |
| 99213 Office E&M - Established | Office | 202 | 148 | $64.57 | $13K |
| 99215 Office E&M - Established | Office | 24 | 22 | $131.38 | $3,153 |
By year: 2022 $49K for 732 services; 2023 $44K for 620 services; 2024 $47K for 599 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 19 | $8.40 | $160 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna Mezentseva prescribed most often to Medicare patients was Amlodipine Besylate, with 464 prescriptions and refills. In total Anna Mezentseva wrote 14,853 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 464 | 486 | 62 | $513 |
| Rosuvastatin Calcium Generic | 427 | 445 | 55 | $1,078 |
| Levothyroxine Sodium Generic | 402 | 445 | 53 | $1,386 |
| Vascepa Icosapent Ethyl | 350 | 352 | 60 | $115K |
| Metformin Hcl Generic | 336 | 368 | 51 | $349 |
| Gabapentin Generic | 314 | 336 | 46 | $1,026 |
| Ibuprofen Generic | 306 | 319 | 64 | $1,460 |
| Meclizine Hcl Generic | 301 | 319 | 43 | $1,423 |
| Metoprolol Succinate Generic | 299 | 317 | 36 | $1,492 |
| Atorvastatin Calcium Generic | 299 | 314 | 47 | $985 |
| Diclofenac Sodium Generic | 275 | 281 | 46 | $137K |
| Losartan Potassium Generic | 262 | 308 | 43 | $613 |
| Furosemide Generic | 245 | 250 | 36 | $285 |
| Ozempic Semaglutide | 242 | 255 | 33 | $237K |
| Tamsulosin Hcl Generic | 227 | 253 | 36 | $504 |
Brand drugs: 2,894 claims; generic drugs: 11,638 claims; opioid claims: 141.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Mezentseva $72.79 ($72.79 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $33.88.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.